School of Health Professions, University of Southern Mississippi, Hattiesburg 39402, MS, USA.
Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens 30602, GA, USA.
Vaccine. 2024 Aug 30;42(21):126149. doi: 10.1016/j.vaccine.2024.07.050. Epub 2024 Jul 29.
Influenza seasons occur annually, building immune history for individuals, but the influence of this history on subsequent influenza vaccine protection remains unclear. We extracted data from an animal trial to study its potential impact. The trial involved 80 ferrets, each receiving either one type of infection or a placebo before vaccination. We quantified the vaccine protection by evaluating hemagglutination inhibition (HAI) antibody titer responses. We tested whether hosts with different infection histories exhibited similar level of responses when receiving the same vaccine for all homologous and heterologous outcomes. We observed that different pre-existing immunities were generally beneficial to vaccine induced responses, but varied in magnitude. Without pre-immunity, post-vaccination HAI titers after the 1st dose of the vaccine were less likely to be above 1:40, and a booster shot was needed. Our study suggests that pre-existing immunity may strengthen and extend the homologous and heterologous vaccine responses.
流感季节每年都会出现,为个体建立免疫史,但这种免疫史对随后的流感疫苗保护的影响尚不清楚。我们从一项动物试验中提取数据来研究其潜在影响。该试验涉及 80 只雪貂,它们在接种疫苗前要么接受一种感染,要么接受安慰剂。我们通过评估血凝抑制(HAI)抗体滴度反应来量化疫苗保护作用。我们测试了具有不同感染史的宿主在接受同种疫苗时,对于所有同源和异源结果,是否表现出相似水平的反应。我们观察到,不同的预先存在的免疫通常有利于疫苗诱导的反应,但程度不同。没有预先免疫,接种疫苗后第一剂疫苗的血凝抑制滴度不太可能超过 1:40,需要进行加强注射。我们的研究表明,预先存在的免疫可能会增强和延长同源和异源疫苗的反应。